BioSpace News Archive

The healthcare industry is in the state of rapid transition, underpinned by rapidly growing array of healthcare IT products in recent decades.

Breakthroughs in medical and administrative technologies, high instances of chronic diseases, high prevalence of various severe diseases, and supportive reimbursement scenario in healthcare industry in developed region are some of the key factors stimulating growth in the global electronic health records market.

A recent report by Transparency Market Research states that global blood gas and electrolyte market is projected to witness a substantial growth in the tenure of 2017 to 2023.

The rising technological advancements across the dental sector are increasing the growth prospects of the dental laboratories market to a great extent.

Transparency Market Research has published a new report titled, ‘Durable medical equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Fact.MR – A Market Research and Competitive Intelligence Provider: Increasing cases of cardiovascular diseases, rising geriatric population, and advancements in fluid management systems are pressing upon the need for advanced hemoconcentrators.

B dot Medical Inc. has conducted an energization test of the scanning magnet, which is designed and manufactured at its factory, for a compact proton cancer therapy system under development, and confirmed the generation of a magnetic field.

Genus, a leading global animal genetics company, announces its preliminary results for the year ended 30 June 2021.

ONK Therapeutics Ltd, an innovative NK cell therapy company, announced that the US Patent and Trademark Office has granted its licensed patent that covers CISH knockout in NK cells, irrespective of the source of the NK cells, including, for example, human cord blood-derived and human induced pluripotent stem cell -derived cells.

ITM AG, a leading radiopharmaceutical company, announced that it will host a virtual industry satellite symposium titled, “A Global Perspective on the Management of Neuroendocrine Tumors – the Evolving Role of Targeted Radionuclide Diagnostics and Therapy” at the European Society of Medical Oncology Congress 2021.